Computational rewiring of allosteric pathways reprograms GPCR selective responses to ligands

Dániel Kéri, Mahdi Hijazi, Aurélien Oggier, Patrick BarthbioRxiv 2022 · DOI

TL;DR

This study uses computational design to rewire allosteric pathways in dopamine D2 receptors, demonstrating that different ligands utilize distinct signaling routes. By precisely manipulating these pathways, researchers can engineer receptors with highly selective responses to specific ligands, offering a powerful new approach for drug design and personalized medicine.

What Problem Does This Paper Address?

G-protein-coupled receptors (GPCRs) are crucial drug targets, involved in a vast array of cellular functions. However, understanding precisely how a ligand binding to a GPCR triggers a specific downstream signaling cascade remains a significant challenge. This complexity arises because GPCRs can respond to various ligands, and a single receptor can activate multiple signaling pathways, leading to functional selectivity or "biased agonism." The paper tackles this by investigating the intricate allosteric signaling mechanisms within the dopamine D2 receptor, aiming to decipher the relationships between ligand structure, receptor dynamics, and the resulting signaling output. This knowledge is vital for designing drugs that can selectively activate desired pathways while avoiding unwanted side effects.

Methods

The researchers employed a multi-disciplinary computational and experimental approach:

  • Ligand Clustering: They analyzed the structural similarity of 39 dopamine D2 receptor agonists using density-based clustering (DBSCAN) and principal component analysis (PCA) to map the chemical space of these ligands.
  • Molecular Dynamics (MD) Simulations: MD simulations were used to explore the allosteric pathways within the receptor, identifying how ligand binding influences protein structure and dynamics.
  • Allosteric Pathway Prediction: Using the MD data, they calculated mutual information between residues to predict allosteric communication pathways and identified "allosteric hubs" – key residues involved in signal transmission.
  • Computational Protein Design: Leveraging the identified pathways, they used a computational design pipeline (RosettaMembrane) to engineer novel receptor variants with altered allosteric signaling properties. This involved in silico mutagenesis to modify specific residues.
  • Cell-Based Assays: Functional validation was performed using a fluorescence-based Transient Receptor Potential (TRP) channel assay to measure G protein Gi activation in response to various ligands and designed receptor variants.
  • Enzyme-linked Immunosorbent Assay (ELISA): Used to confirm that engineered receptor variants expressed at comparable levels to the wild-type receptor.
  • Ligand Docking: Used to predict the binding modes of ligands within the receptor.

Datasets

  • CHEMBL Database: A list of dopamine D2 receptor agonists was obtained from the CHEMBL database.
  • Dopamine D2 Receptor Structures: Used for docking and simulations, including the Gi-bound active state D2 structure (PDB code 6VMS).

Key Insights and Ideas

  • Ligand-Specific Allosteric Pathways: The study strongly suggests that different ligands, even those binding to the same receptor, utilize distinct allosteric pathways to communicate with intracellular signaling partners. This is a fundamental shift from a single, unified signaling mechanism.
  • Rewiring for Selectivity: By precisely targeting and manipulating these ligand-specific allosteric pathways through computational design, it's possible to engineer receptors that exhibit highly selective responses to particular ligands. This opens up avenues for creating drugs with unprecedented specificity.
  • Structure-Function Relationship: The research highlights a clear correlation between ligand structural similarity and the resulting signaling response, reinforcing the importance of understanding ligand-receptor interactions at a molecular level.
  • "Allosteric Activator" Moieties: The findings propose that specific "allosteric activator" moieties within ligands engage partially independent signal transmission networks within GPCRs, leading to distinct functional outcomes.

Key Results

  • Designed Variants Show Selective Responses: Engineered D2 receptor variants demonstrated significantly different G-protein signaling responses to various ligands, with these differences correlating with ligand structural similarity.
  • Enhanced Sensitivity and Efficacy: Several designed microswitches in the receptor's transmembrane core led to gain-of-function effects, enhancing ligand sensitivity and efficacy for specific agonists, particularly dopamine and serotonin.
  • Highly Selective Receptor Engineering: A second generation of designed receptors achieved high ligand selectivity, with one variant showing a strong preference for dopamine while completely losing its response to bromocriptine.
  • Computational Predictions Validated Experimentally: The computational predictions of allosteric pathway rewiring and subsequent functional changes were largely validated by experimental measurements of Gi activation.

Limitations and Future Work

  • Model System: While the dopamine D2 receptor is a well-studied model, the findings' generalizability to other GPCRs will require further investigation.
  • Complexity of Allostery: The intricate nature of allosteric signaling means that fully predicting and controlling all outcomes remains a complex endeavor.
  • Future Directions: The authors suggest that this rational rewiring of allosteric pathways can be used to engineer highly selective ligand biosensors and to predict the impact of receptor polymorphisms on drug pharmacology, paving the way for personalized medicine. Further exploration of different GPCRs and ligand classes is also implied.

Summary updated

Abstract

Abstract G-protein-coupled receptors (GPCRs) are the largest class of cell surface receptors and drug targets, and respond to a wide variety of chemical stimuli to activate diverse cellular functions. Understanding and predicting how ligand binding triggers a specific signaling response is critical for drug discovery and design but remains a major challenge. Here, computational design of GPCR allosteric functions is used to uncover the mechanistic relationships between agonist ligand chemistry, receptor sequence, structure, dynamics and allosteric signaling in the dopamine D2 receptor. Designed gain of function D2 variants for dopamine displayed very divergent G-protein signaling responses to other ligand agonists that strongly correlated with ligand structural similarity. Consistent with these observations, computational analysis revealed distinct topologies of allosteric signal transduction pathways for each ligand-bound D2 pair that were perturbed differently by the designs. We leveraged these findings by rewiring ligand-specific pathways and designed receptors with highly selective ligand responses. Overall, our study suggests that distinct ligand agonists can activate a given signaling effector through specific “allosteric activator” moieties that engage partially independent signal transmission networks in GPCRs. The results provide a mechanistic framework for understanding and predicting the impact of sequence polymorphism on receptor pharmacology, informing selective drug design and rationally designing receptors with highly selective ligand responses for basic and therapeutic applications.
BibTeX
@misc{keri2022computational,
  author = {Dániel Kéri and Mahdi Hijazi and Aurélien Oggier and Patrick Barth},
  title = {{Computational rewiring of allosteric pathways reprograms GPCR selective responses to ligands}},
  year = {2022},
  doi = {10.1101/2022.03.30.486353},
  howpublished = {bioRxiv},
}
Figure